| Mona Patel, MD | |
|
1041 W Stearns Rd, Bartlett, IL 60103-4509 | |
| (630) 716-7500 | |
| Not Available |
| Full Name | Mona Patel |
|---|---|
| Gender | Female |
| Speciality | Pain Management |
| Experience | 11 Years |
| Location | 1041 W Stearns Rd, Bartlett, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154663441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 036138854 (Illinois) | Primary |
| 207LP2900X | Anesthesiology - Pain Medicine | 036138854 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alexian Brothers Medical Center 1 | Elk grove village, IL | Hospital |
| St Alexius Medical Center | Hoffman estates, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bonaventure Medical Foundation Llc | 7517863178 | 153 |
News Archive
Parents and healthcare professionals must be aware that children can have strokes and be prepared to respond to symptoms, according to research presented at the American Stroke Association's International Stroke Conference 2014.
An international collaboration of scientists, including researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health, has identified a genetic mutation that causes a rare childhood disease characterized predominantly by inflammation and fat loss.
A new study reveals that couple who think money and things before everything else might be worse off in their relationships than those who aren't as materialistic. The study was published in the Journal of Couple & Relationship Therapy.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 6 days ago
| Entity Name | Bonaventure Medical Foundation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588775647 PECOS PAC ID: 7517863178 Enrollment ID: O20031212000374 |
News Archive
Parents and healthcare professionals must be aware that children can have strokes and be prepared to respond to symptoms, according to research presented at the American Stroke Association's International Stroke Conference 2014.
An international collaboration of scientists, including researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health, has identified a genetic mutation that causes a rare childhood disease characterized predominantly by inflammation and fat loss.
A new study reveals that couple who think money and things before everything else might be worse off in their relationships than those who aren't as materialistic. The study was published in the Journal of Couple & Relationship Therapy.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mona Patel, MD 1555 Barrington Rd Ste 2400, Hoffman Estates, IL 60169-1063 Ph: (847) 981-3630 | Mona Patel, MD 1041 W Stearns Rd, Bartlett, IL 60103-4509 Ph: (630) 716-7500 |
News Archive
Parents and healthcare professionals must be aware that children can have strokes and be prepared to respond to symptoms, according to research presented at the American Stroke Association's International Stroke Conference 2014.
An international collaboration of scientists, including researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health, has identified a genetic mutation that causes a rare childhood disease characterized predominantly by inflammation and fat loss.
A new study reveals that couple who think money and things before everything else might be worse off in their relationships than those who aren't as materialistic. The study was published in the Journal of Couple & Relationship Therapy.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
Kaiser Health News asked a tax expert to explain who will be eligible for this assistance and how the process will work. Meanwhile, The Washington Post examines how the overhaul is linked to work-hour caps for part-timers.
› Verified 6 days ago